HEALTHY EXTRACTS INC.
15.7.2024 13:34:47 CEST | ACCESS Newswire | Press release
LAS VEGAS, NV / ACCESSWIRE / July 9, 2024 / Healthy Extracts Inc. (OTCQB:HYEX), a comprehensive platform for acquiring, developing, patenting and marketing plant-based nutraceuticals in the multibillion-dollar nutraceuticals market, reported preliminary record results for the second quarter ended June 30, 2024.
Net revenue is expected to exceed a record $900,000, which would be up more than 30% from the previous quarter and up more than 50% compared to the same year-ago quarter.
Gross margin for the quarter is expected to exceed 53%, driving positive operating cash flow. Excluding non-core and non-cash expenses, the company expects to report its third sequential quarter of net profitability.
"Our record top-line, margin expansion and improved cash flow for the quarter was driven by strong direct-to-consumer and wholesale revenue growth," commented Healthy Extracts president, Duke Pitts. "Even excluding wholesale, we still exceeded our previously stated outlook for the quarter, demonstrating increased traction with our target retail customer base."
The quarter's performance has put the company on a solid financial foundation for generating cash flow and servicing debt deployed as growth capital. In fact, during the quarter, the company paid down more than $100,000 in debt while increasing its cash position.
In April, the company reported the restructuring and streamlining of debt that resulted in an additional $15,000 a month in positive cash flow. The company expects to report its third cash flow positive quarter in a row at more than $140,000. The company plans to deploy the cash into further expanding its product offerings and revenue streams, including recurring revenue from product subscriptions.
Added Pitts: "For the remainder of the year, we expect continued strong progress with top-line growth, increased cash flow, profitability and market share expansion as our addressable markets continue to strengthen. This will be largely driven by the launch of new products that will leverage our well-established, broad market channels we have strategically invested in and developed over the last several years. These investments have shown to be the best formula for building attractive shareholder value."
Please note that the preliminary unaudited results presented in this press release are estimates only and are subject to revision until the company officially reports its quarterly results in mid-August.
About Healthy Extracts "Live Life Young Again"
Healthy Extracts Inc.is a platform for acquiring, developing, researching, patenting, marketing, and distributing plant-based nutraceuticals.
The company's subsidiaries, BergametNA™ and Ultimate Brain Nutrients™ (UBN), offer nutraceutical natural heart and brain health supplements. This includes the only heart health supplement distributed in North America containing Citrus Bergamot SuperFruit™. This superfruit has the highest known concentration of polyphenols and flavonoids.
UBN's KETONOMICS® proprietary formulations, which have been designed to enhance brain activity, focus, headache and cognitive behavior, provide many sales and intellectual property licensing opportunities.
For more information visit: healthyextractsinc.com, bergametna.com or tryubn.com.
Forward-Looking Statements and Safe Harbor Notice
All statements other than statements of historical facts included in this press release are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). Such forward-looking statements include our expectations and those statements that use forward-looking words such as "projected," "expect," "possibility" and "anticipate." The achievement or success of the matters covered by such forward-looking statements involve significant risks, uncertainties and assumptions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors set forth in the Company's Annual Report on Form 10-K as filed with the SEC, and future periodic reports filed with the SEC. All of the Company's forward-looking statements are expressly qualified by all such risk factors and other cautionary statements. The Company cautions that statements and assumptions made in this news release constitute forward-looking statements and make no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. The information set forth herein speaks only as of the date hereof. The Company and its management undertake no obligation to revise these statements following the date of this news release.
Food & Drug Administration Disclosure
The products and formulations mentioned in this release are not for use by or sale to persons under the age of 12. The products should be used only as directed on the label. Consult a physician before use if you have a serious medical condition or use prescription medications. A doctor's advice should be sought before using this and any supplemental dietary product. These statements have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure or prevent any disease.
BergametNA™, Ultimate Brain Nutrients™, UBN™, Citrus Bergamot SuperFruit™ and F4T® are registered trademarks of Healthy Extracts Inc.™
Company Contact
Duke Pitts, President
Healthy Extracts Inc.
Tel (720) 463-1004
Email contact
Investor Contact
Ronald Both
CMA Investor Relations
Tel (949) 432-7566
Email contact
Media Contact:
Tim Randall
CMA Media Relations
Tel (949) 432-7572
Email Contact
SOURCE: Healthy Extracts Inc.
View the original press release on accesswire.com
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Chervon Names Matthew H. DeFeo as Senior Vice President of Sales, Training and Recruiting15.9.2026 00:00:00 CEST | Press release
Accomplished Power Tools and Outdoor Power Equipment industry leader brings decades of experience in sales leadership, talent recruitment and development, channel management, and key account alignment NAPERVILLE, IL / ACCESS Newswire / September 14, 2026 / Matthew DeFeo joins Chervon as Senior Vice President of Sales, Training, and Recruiting effective September 14, 2026, reporting to CEO Joe Galli. Matthew DeFeo brings more than four decades of experience in the power tool and outdoor power equipment industry. He has an exceptional track record in building and leading large sales organizations, channel marketing teams, and training and development teams. DeFeo is widely recognized as a world-class leader in the campus recruiting of high potential graduates. He has built out impressive in-store sales coverage teams, end user marketing teams, campus recruiting teams, and training teams with an intense focus on key account alignment. A hallmark of DeFeo's remarkable career is his mentors
Chervon Names Jeffrey P. Campbell Senior Vice President of Industrial Commercial Sales14.9.2026 23:50:00 CEST | Press release
NAPERVILLE, IL / ACCESS Newswire / September 14, 2026 / Jeffrey P. Campbell joins Chervon as Senior Vice President of Industrial Commercial Sales effective Monday, September 14, 2026, reporting to CEO Joe Galli. Campbell joins Chervon with 25 years of exceptional executive leadership experience in the professional tool industry. He has built and led high-performance sales and channel marketing teams, developed strategic key account partnerships and has consistently driven strong growth across all professional and automotive channels of distribution. In his new role, Campbell will lead Chervon's Industrial / Commercial Sales network serving the many professional and automotive tool channels. "Jeff brings an impressive and unmatched combination of professional and automotive channel sales leadership, channel management, customer partnership skills and organizational development," said Joe Galli, CEO of Chervon. "His exhaustive command of our channels, key accounts, and users, combined wi
AGFA HealthCare Puts Clinical Attention at the Center of Enterprise Imaging at RSNA 202614.9.2026 16:30:00 CEST | Press release
One unified Enterprise Imaging platform brings workflow, streaming, cloud, and AI together to help clinicians stay focused and imaging organizations reduce complexity. CARLSTADT, NJ / ACCESS Newswire / September 14, 2026 / "Clinical attention has become one of healthcare's most valuable resources. The technology surrounding clinicians should preserve focus, not compete for it," said Nathalie McCaughley, President, AGFA HealthCare. "At RSNA 2026, we're showing how Enterprise Imaging continues to evolve around one consistent clinical experience. By bringing workflow, intelligence, and information together around how clinicians naturally work, we can reduce friction and help keep clinical attention where it matters most." At RSNA 2026, AGFA HealthCare will demonstrate how a unified approach to Enterprise Imaging can help healthcare organizations address a growing challenge: imaging volumes and clinical complexity continue to increase, while radiologists and imaging teams are being asked t
Litum Expands PathAware from Collision Warning to Forklift Safety Intelligence14.9.2026 08:00:00 CEST | Press release
PathAware® now turns collision risks, near misses and operator activity into actionable safety intelligence, while adding operator control, digital inspections and utilization insights, all through a retrofit system built for mixed forklift fleets. BOSTON, MA / ACCESS Newswire / September 14, 2026 / Litum today announced PathAware® IQ and PathAware® IQ+, expanding its forklift collision warning technology into a connected safety intelligence platform. PathAware IQ not only warns operators when risks occur. It captures safety events across the fleet and turns them into visual dashboards and actionable data, giving safety teams visibility into recurring risks, near misses, operators, vehicles, areas and shifts. This allows organizations to move from reacting to incidents to identifying patterns earlier, targeting operator training, addressing recurring hazards and measuring whether safety actions are actually working. PathAware IQ+ builds on that intelligence with digital pre-operation i
Surmodics Opens Medical Device Coating Capabilities in Ireland10.9.2026 16:00:00 CEST | Press release
The Galway Facility Brings Nearly 50 Years of Coating Expertise, Cleanroom Coating Services and Analytical Testing Closer to Medical Device Manufacturers Across Ireland and Europe BALLINASLOE, COUNTY GALWAY, IRELAND / ACCESS Newswire / September 10, 2026 / Surmodics, Inc. today announced its expanded medical device coating capabilities in Galway, Ireland, expanding access to the company's Performance Coatings and coating services for medical device manufacturers throughout Ireland and Europe. The facility now includes dedicated cleanroom environments designed for medical device coating services and brings Surmodics' nearly 50 years of coating experience closer to one of the world's leading medical technology hubs. "Ireland is home to a significant concentration of medical device manufacturers and technology innovators, making it an important market for Surmodics and our customers," said Damien Kilcommons, Vice President of Site Operation at the Ireland facility. "By establishing dedica
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
